{
    "organizations": [],
    "uuid": "2e671790ac1d5376cd8d1eb04a69dec587b10814",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-cti-biopharma-reports-q1-eps-loss/brief-cti-biopharma-reports-q1-eps-loss-per-share-of-0-08-idUSASC09ZN1",
    "ord_in_thread": 0,
    "title": "Cti Biopharma Reports Q1 EPS Loss Per Share Of $0.08",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 3 (Reuters) - CTI Biopharma Corp:\n* CTI BIOPHARMA REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS\n* Q1 REVENUE $10.5 MILLION VERSUS $800,000 * AS OF MARCH 31, 2018, CASH AND CASH EQUIVALENTS TOTALED $104.6 MILLION, COMPARED TO $43.2 MILLION AS OF DECEMBER 31, 2017 Source text for Eikon:\nOur ",
    "published": "2018-05-04T04:15:00.000+03:00",
    "crawled": "2018-05-04T16:41:35.010+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "cti",
        "biopharma",
        "corp",
        "cti",
        "biopharma",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "q1",
        "revenue",
        "million",
        "versus",
        "march",
        "cash",
        "cash",
        "equivalent",
        "totaled",
        "million",
        "compared",
        "million",
        "december",
        "source",
        "text",
        "eikon"
    ]
}